| Battenkill Valley Health Center, Inc | |
|
9 Church St Arlington VT 05250 | |
| (802) 375-6566 | |
| (802) 375-6828 |
| Full Name | Battenkill Valley Health Center, Inc |
|---|---|
| Speciality | Clinic/Center |
| Location | 9 Church St, Arlington, Vermont |
| Authorized Official Name and Position | Jennifer Petry (DIRECTOR OF PRACTICE ADMINISTRATION) |
| Authorized Official Contact | 8024307254 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Battenkill Valley Health Center, Inc Po Box 61 Arlington VT 05250 Ph: (802) 375-6566 | Battenkill Valley Health Center, Inc 9 Church St Arlington VT 05250 Ph: (802) 375-6566 |
| NPI Number | 1033530696 |
|---|---|
| Provider Enumeration Date | 12/30/2013 |
| Last Update Date | 07/24/2018 |
| Medicare PECOS PAC ID | 2769612548 |
|---|---|
| Medicare Enrollment ID | O20140221001014 |
News Archive
The largest study ever of breast cancer in Latin American women is being launched this year in a unique multi-country, public/private partnership with $1 million in additional funding from the world's largest breast cancer organization, Susan G. Komen for the Cure®.
Using nanoparticles designed specifically to produce a bright Raman spectroscopic signal, a team of investigators at the Center for Cancer Nanotechnology Excellence Focused on Therapy Response (Stanford University Center for Cancer Nanotechnology Excellence [CCNE]) has shown that it can simultaneously track as many as 10 different optical tags in a living animal.
Inspire Pharmaceuticals, announced today a strategic corporate restructuring designed to result in the Company focusing activities on its eye care business, allowing it to fully leverage existing commercial capabilities, pipeline assets and related corporate development and licensing opportunities.
A number of previous scientific studies have found that among mothers 35 or older, there is an elevated risk that their children are born preterm (less than 37 weeks of pregnancy) or with low birth weight (less than 2.5 kilograms).
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033530696 | NPI | - | NPPES |
News Archive
The largest study ever of breast cancer in Latin American women is being launched this year in a unique multi-country, public/private partnership with $1 million in additional funding from the world's largest breast cancer organization, Susan G. Komen for the Cure®.
Using nanoparticles designed specifically to produce a bright Raman spectroscopic signal, a team of investigators at the Center for Cancer Nanotechnology Excellence Focused on Therapy Response (Stanford University Center for Cancer Nanotechnology Excellence [CCNE]) has shown that it can simultaneously track as many as 10 different optical tags in a living animal.
Inspire Pharmaceuticals, announced today a strategic corporate restructuring designed to result in the Company focusing activities on its eye care business, allowing it to fully leverage existing commercial capabilities, pipeline assets and related corporate development and licensing opportunities.
A number of previous scientific studies have found that among mothers 35 or older, there is an elevated risk that their children are born preterm (less than 37 weeks of pregnancy) or with low birth weight (less than 2.5 kilograms).
› Verified 2 days ago
Battenkill Valley Health Center Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 9 Church St, Arlington, VT 05250 Phone: 802-375-6566 Fax: 802-375-6828 |